MPTP-Hydrochloride
CAS No. 23007-85-4
MPTP-Hydrochloride( 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | NSC 139654 )
Catalog No. M13642 CAS No. 23007-85-4
MPTP (hydrochloride) is a prodrug to the neurotoxin MPP which causes permanent symptoms of Parkinson's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 44 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 131 | In Stock |
|
| 100MG | 183 | In Stock |
|
| 200MG | 291 | In Stock |
|
| 500MG | 461 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMPTP-Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionMPTP (hydrochloride) is a prodrug to the neurotoxin MPP which causes permanent symptoms of Parkinson's disease.
-
DescriptionMPTP (hydrochloride) is a prodrug to the neurotoxin MPP which causes permanent symptoms of Parkinson's disease.(In Vitro):Pretreatment with 50 mM 4-phenylpyridine, reduces IC50 (concentration for 50% inhibition of twitch amplitude) values of MPTP from 53 to 18 mM and d-tubocurarine from 0.7 to 0.3 mM, respectively, in mouse phrenic nerve-diaphragm.(In Vivo):The toxic effect of MPTP can be completely abolished in vivo by treatment with a monoamine oxidase inhibitor and potentiated by an inhibitor of catechol-O-methyltransferase. Gas1 expressions are significantly elevated in the majority of the reactive astrocytes of the brains with LPS or MPTP insults in animal models.
-
In Vitro——
-
In Vivo——
-
Synonyms1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | NSC 139654
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number23007-85-4
-
Formula Weight209.72
-
Molecular FormulaC12H16ClN
-
Purity>98% (HPLC)
-
SolubilityDMSO: 12 mg/mL
-
SMILESCN1CCC(=CC1)C2=CC=CC=C2.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Langston J W, Irwin I. MPTP Neurotoxicity: An Overview and Characterization of Phases of Toxicity. II. Selective Accumulation of MPP in the Substantia Nigra: A Key to Neurotoxicity (Question). Life Sci., 1985, 36, No. 3, 201-12.
molnova catalog
related products
-
Tedatioxetine
Tedatioxetine (Lu AA24530) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) with antidepressant properties.Tedatioxetine acts as a CYP2D6 substrate.
-
GSK 789472 hydrochlo...
GSK 789472 hydrochloride is both a dopamine D3 receptor antagonist and a D2 partial agonist.
-
Perphenazine dihydro...
Perphenazine dihydrochloride is an orally active dopamine receptor and histamine-1 receptor antagonist that acts on D2 (Ki: 0.56 nM), D3 (Ki: 0.43 nM), and 5-HT2A (Ki: 0.6 nM) receptors, and also binds Alpha-1A adrenergic receptors.
Cart
sales@molnova.com